12479 results for
Refine Your Search
Blood Cancer United National Patient Registry
A project of the Michael J. Garil Patient Data Collective
Sunbelt Rentals Announces Partnership with The Leukemia & Lymphoma Society to Help Blood Cancer Patients and Their Families
The partnership agreement names Sunbelt Rentals as the National Presenting Partner for LLS’s philanthropic program Student Visionaries of the Year
Barclays Ajay Kataria is on a Mission to End Blood Cancer
Congratulations to Ajay Kataria, Head of BARX FX Sales, Americas, who was just awarded the ‘Citizenship Achievement of the Year – Americas’ at Barclay…
Breaking Data Presented at ASCO 2024 Showcase Breadth of The Leukemia & Lymphoma Society Therapy Acceleration Program Impact on Key Blood Cancer Research
RYE BROOK, N.Y., May , – Four companies supported by The Leukemia & Lymphoma Society Therapy Acceleration Program (LLS TAP) are presenting new data f…
Bringing Light to The Darkness of Cancer: BeiGene Named National Partner of Survivorship and Hope for The Leukemia & Lymphoma Society’s Light The Night
Rye Brook, NY, March , – The Leukemia & Lymphoma Society (LLS) announced today that BeiGene, Ltd., a global oncology company, has signed a partnersh…
Subaru Partners with The Leukemia & Lymphoma Society for 8th Year to Share Warmth, Love and Relief with Patients Facing Cancer
Rye Brook, N.Y. – June , – Subaru of America, Inc. today announced that it will renew its partnership with The Leukemia & Lymphoma Society (LLS) duri…
Stacking Up Hope: 75 Participating IHOP Locations Unite with The Leukemia & Lymphoma Society to Support Blood Cancer Patients
Latest Campaign Reinforces IHOP's -Year Commitment to Raising Funds for LLS’s Mission
Site-Neutral Reforms in Medicare Could Make Health Care More Affordable
Study quantifies hundreds of dollars of savings with payment proposals.
Resources for Blood Cancer Patients and Families Affected by the California Wildfires
In light of the California Wildfires, we join the nation in sadness for the loss of life and concern about the devastating impact on communities, fami…
Recent FDA Approval a ‘Great Step in the Right Direction’ for Improving Quality of Life in Blood Cancer Patients
The FDA has approved a liquid form of ibrutinib for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), Waldenstrom macro…
Recent FDA Approval Gives More Myeloma Patients Chance at Long-Term Remission with a Stem Cell Transplant
Rye Brook, N.Y., September , – The U.S. Food and Drug Administration (FDA) recently approved motixafortide (Aphexda™) in combination with filgrastim …
Oral Formulation of Methotrexate Now Available for Children with Leukemia Subtype
New formulation of key blood cancer treatment offers important option for children, may help with ongoing cancer drug shortages Rye Brook, N.Y., Decem…
In the Face of Uncertainty in Washington, The Leukemia & Lymphoma Society Stands with Patients
January , – This week, LLS has heard great concern from patients, caregivers, volunteers, healthcare professionals, researchers, community organizati…
FDA Approves a CAR T-cell Therapy to Treat Adults with a Form of Acute Leukemia
The Leukemia & Lymphoma Society (LLS) was an early champion and funder of CAR therapy Rye Brook, N.Y., December , – The U.S. Food and Drug Administr…
FDA Approves Combination Treatment for Lymphoma Subtype that has Returned or Worsened
WASHINGTON, February , – The U.S. Food and Drug Administration has approved brentuximab vedotin (Adcetris®) to treat adults with large lymphoma, who…
FDA Approves Drug Designed to Target Specific Mutation in Rare Blood Cancer Type
The Leukemia & Lymphoma Society has provided funding to research that identified novel ways to attack the IDH mutation in patients with blood cancers.…
FDA Approves First Ever BTK Inhibitor to Treat Lymphoma Subtype
Rye Brook, N.Y., March , – The U.S. Food and Drug Administration approved zanubrutinib (Brukinsa®) in combination with obinutuzumab (Gazyva®) to trea…
FDA Approves First of a New Class of Drugs to Treat Advanced Acute Leukemia
The Leukemia & Lymphoma Society (LLS) helped every step of the way in discovery and development of menin inhibitors Rye Brook, N.Y., December , – The…
Communities Across the U.S. to Join Olympians at Legendary Deer Valley Resort to End Blood Cancer
Communities Across the U.S. to Join Olympians at Legendary Deer Valley Resort to End Blood Cancer
Newly FDA-approved Treatment Enhances Survival for Children and Adults with 2 Blood Cancer Types
The FDA approval will benefit children and adults with acute myeloid leukemia (AML), and myelodysplastic syndromes (MDS). Rye Brook, N.Y., January , …
New LLS Docuseries on CAR T-cell Advances Aims to Educate and Empower Blood Cancer Patients
Patient Accounts Provide Unique InsightWASHINGTON, MARCH , – The Leukemia & Lymphoma Society (LLS) has launched a new docuseries to inform blood canc…
New Formulation of Important CML Drug Comes with No Mealtime Restrictions
Nilotinib is a targeted treatment that offers control of CML Rye Brook, N.Y., December , – The U.S. Food and Drug Administration (FDA) has approved …
New $20 Million Research Funding Program Aims to ‘Accelerate a Cure’ for Follicular Lymphoma
The Leukemia & Lymphoma Society and the Institute for Follicular Lymphoma Innovation commit $ million to jointly fund follicular lymphoma research.RYE…
Nearly 1 in 2 Patients with Medical Debt Feel “Trapped”, New Poll from Leading Healthcare Orgs Finds
Almost of patients would blame elected officials if they fail to act.
Education Resources
MOD PIZZA PARTNERS WITH THE LEUKEMIA & LYMPHOMA SOCIETY TO HELP KIDS WITH BLOOD CANCER
Funds Raised to Benefit the Work of LLS’s The Dare to Dream Project to Bring Safer, Less Toxic Treatments for Kids with Blood Cancer & Provide Free Su…